|
We asked 40 pharma leaders, do you think the growing number of anti-counterfeiting technologies, coupled with increased focus from regulators, have had a positive impact on reducing the number of counterfeit pharmaceuticals in the legal supply chain?
| Yes |
50% |
| No |
16% |
| Technologies have but regulations are still inadequate |
26% |
| Regulations have but technologies are still inadequate |
8% |
 |
|
|
|
|
|
|
|
